Liver Diseases Completed Phase 1 Trials for Naproxcinod (DB06682)

Also known as: Liver Disease / Diseases of liver (K70-K77) / Hepatic pathology / Fector hepaticus / [X]Diseases of the liver / Hepatopathy / Hepatic disease NOS / Hepatic disorder (NOS) / Disorder hepatic / Hepatic disorder NOS / Disease hepatocellular / Disorder liver / Hepatic disease / Hepatic disease (NOS) / Liver disorder / Unspecified disorder of liver

IndicationStatusPhase
DBCOND0027940 (Liver Diseases)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00621881A Phase 1 Study to Compare the PK and Safety of Naproxcinod in Hepatic Impaired Patients and Matching Healthy SubjectsBasic Science